Received Sep 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 50-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. The patient's past medical history included 1st degree heart block (2 to 3 years ago). Concurrent medical conditions included Allergy. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medication was reported. It was reported that she wanted to confirm if the mNEXSPIKE booster was safe for her and if it was going to give her a hard time with age. Her healthcare provider assured her that it was safe to take. She explained that she had a first-degree heart block and, 2 to 3 years ago, had to postpone her COVID-19 booster due to a scheduled breast ultrasound. During that time, she contracted COVID-19 and subsequently received the vaccine later. Her entire department at work also contracted the virus around the same time, which she attributed to being outdoors without masks and being in the wrong place at the wrong time. She noted that she couldn't distinguish between her allergy symptoms and COVID-19. However, she confirmed that she did not contract COVID-19 from the vaccine, and she believed that timely vaccination could prevented some of the issues she experienced. It was unknown if the patient experienced any additional symptoms or events. No treatment medication was reported. Reporter did not allow further contact
Allergy
Medical History/Concurrent Conditions: 1st degree heart block (2 to 3 years ago)